04:34 PM EDT, 05/09/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) reported a fiscal Q2 loss late Thursday of $1.02 per diluted share, compared with earnings of $0.45 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.22.

The company did not report any revenue for the quarter that ended March 31, compared with $146.3 million a year earlier.

Analysts surveyed by Capital IQ expected $56.8 million.

Shares of the company traded 1.7% lower in after-hours activity.

Price: 24.30, Change: -0.42, Percent Change: -1.70